UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 321

Sortiert nach

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

Cancer Immunology, Immunotherapy, 2023-07, Vol.72 (7), p.2099-2111

2023

Volltextzugriff (PDF)

An optimized multi-parameter flow cytometry protocol for human T regulatory cell analysis on fresh and viably frozen cells, correlation with epigenetic analysis, and comparison of cord and adult blood

Journal of immunological methods, 2013-01, Vol.387 (1-2), p.81-88

2013

Volltextzugriff (PDF)

Graft-Versus-Leukemia Reactions After Bone Marrow Transplantation

Blood, 1990-02, Vol.75 (3), p.555-562

1990

Volltextzugriff (PDF)

Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells

The Journal of immunology (1950), 2001-01, Vol.166 (1), p.89-94

2001

Volltextzugriff (PDF)

Gene Gun-Mediated Skin Transfection with Interleukin 12 Gene Results in Regression of Established Primary and Metastatic Murine Tumors

Proceedings of the National Academy of Sciences - PNAS, 1996-06, Vol.93 (13), p.6291-6296

1996

Volltextzugriff (PDF)

Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: Report of a phase I/IB study

Human gene therapy, 2002-09, Vol.13 (14), p.1711-1721

2002

Volltextzugriff (PDF)

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma : A report of the children's cancer group

Cancer, 1997-07, Vol.80 (2), p.317-333

1997

Volltextzugriff (PDF)

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients

Clinical cancer research, 1997-08, Vol.3 (8), p.1277-1288

1997

Volltextzugriff (PDF)

Effective Particle-mediated Vaccination against Mouse Melanoma by Coadministration of Plasmid DNA Encoding Gp100 and Granulocyte-Macrophage Colony-Stimulating Factor

Clinical cancer research, 2001-04, Vol.7 (4), p.952-961

2001

Volltextzugriff (PDF)

Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2)

Clinical cancer research, 1996-12, Vol.2 (12), p.1951-1959

1996

Volltextzugriff (PDF)

Identification of a Direct Interaction between Interleukin 2 and the p64 Interleukin 2 Receptor γ Chain

Proceedings of the National Academy of Sciences - PNAS, 1993-03, Vol.90 (6), p.2428-2432

1993

Volltextzugriff (PDF)

Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer

Human gene therapy, 2001-01, Vol.12 (2), p.149-160

2001

Volltextzugriff (PDF)

Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group

Journal of clinical oncology, 1998-03, Vol.16 (3), p.914-919

1998

Volltextzugriff (PDF)

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta

The Journal of immunology (1950), 1987-04, Vol.138 (8), p.2728

1987

Volltextzugriff (PDF)

Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes

Journal of leukocyte biology, 1989, Vol.45 (1), p.29-34

1989

Volltextzugriff (PDF)

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study

Journal of clinical oncology, 2000-12, Vol.18 (24), p.4077

2000

Volltextzugriff (PDF)

Pharmacokinetics and stability of the ch14.18-interleukin-2 fusion protein in mice

Cancer Immunology, Immunotherapy, 1999-08, Vol.48 (5), p.219-229

1999

Volltextzugriff (PDF)

Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study

Clinical cancer research, 1996-02, Vol.2 (2), p.319-330

1996

Volltextzugriff (PDF)

Specific Enzyme-Linked Immunosorbent Assays for Quantitation of Antibody-Cytokine Fusion Proteins

Clinical and Diagnostic Laboratory Immunology, 1999-03, Vol.6 (2), p.236

1999

Volltextzugriff (PDF)

Distinct Clinical and Laboratory Activity of Two Recombinant Interleukin-2 Preparations

Clinical cancer research, 1999-02, Vol.5 (2), p.281-289

1999

Volltextzugriff (PDF)

Severe Combined Immunodeficiency, Interleukin-2 (IL-2), and the IL-2 Receptor: Experiments of Nature Continue to Point the Way

Blood, 1994-02, Vol.83 (3), p.626-635

1994

Volltextzugriff (PDF)

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

The New England journal of medicine, 2010-09, Vol.363 (14), p.1324-1334

2010

Volltextzugriff (PDF)

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma

Human gene therapy, 1997-05, Vol.8 (7), p.875-891

1997

Volltextzugriff (PDF)

WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis

Infection and Immunity, 1992-10, Vol.60 (10), p.4291-4300

1992

Volltextzugriff (PDF)

Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy

Clinical cancer research, 1998-05, Vol.4 (5), p.1287-1296

1998

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(234)

Publikationsform

Sprache

Englisch
(321)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(19)
Journal Of Immunotherapy
(16)
The Journal Of Immunology
(15)
Transplantation Proceedings
(15)
Cancer Immunology Immunotherapy
(14)
Cancer Research
(13)
Cancer Immunology, Immunotherapy : Cii
(12)
Cancer
(11)
Cancer Immunology And Immunotherapy
(10)
Clinical Cancer Research
(10)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

An optimized multi-parameter flow cytometry protocol for human T regulatory cell analysis on fresh and viably frozen cells, correlation with epigenetic analysis, and comparison of cord and adult blood

Graft-Versus-Leukemia Reactions After Bone Marrow Transplantation

Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells

Gene Gun-Mediated Skin Transfection with Interleukin 12 Gene Results in Regression of Established Primary and Metastatic Murine Tumors

Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: Report of a phase I/IB study

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma : A report of the children's cancer group

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients

Effective Particle-mediated Vaccination against Mouse Melanoma by Coadministration of Plasmid DNA Encoding Gp100 and Granulocyte-Macrophage Colony-Stimulating Factor

Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2)

Identification of a Direct Interaction between Interleukin 2 and the p64 Interleukin 2 Receptor γ Chain

Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer

Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta

Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study

Pharmacokinetics and stability of the ch14.18-interleukin-2 fusion protein in mice

Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study

Specific Enzyme-Linked Immunosorbent Assays for Quantitation of Antibody-Cytokine Fusion Proteins

Distinct Clinical and Laboratory Activity of Two Recombinant Interleukin-2 Preparations

Severe Combined Immunodeficiency, Interleukin-2 (IL-2), and the IL-2 Receptor: Experiments of Nature Continue to Point the Way

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma

WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis

Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy

Suchergebnisse filtern